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S U M M A R Y
Background: In late 2009/early 2010, approximately 2000 people were affected by a mysterious viral
outbreak in a southern district of Tamil Nadu; this particularly affected those living in coastal areas.
Blood samples from affected patients were sent for clinical analysis to determine the actual cause of the
illness, but reports were inconclusive.
Methods: The present study describes the clinical observations and laboratory investigations involving
molecular methods performed on 170 of the 2000 clinically suspected cases. These were patients who
were admitted to Aravind Eye Hospital, Madurai, Tamil Nadu with ocular complications. Conventional
reverse transcription polymerase chain reaction (RT-PCR), real-time RT-PCR, and reverse transcription
loop-mediated isothermal gene ampliﬁcation (RT-LAMP) assays were used to detect West Nile virus
(WNV) infection. Further investigation of the genetic diversity of the WNV implicated in ocular
complications was undertaken by sequence phylogeny.
Results: Out of 170 samples, 25 (15%) were positive for chikungunya IgM antibody, 10 (6%) for
chikungunya antigen, and 30 (18%) were positive for dengue IgM antibody. The remaining 105
seronegative samples were further processed for WNV detection by IgM capture ELISA and molecular
methods. Out of the 105 samples, 35 (33%) were positive for WNV IgM antibody, 15 (14%) were positive
for WNV by RT-PCR, and 27 (26%) were found to be positive for WNV by both real-time RT-PCR and RT-
LAMP assays. Comparative evaluation with acute-phase patient serum samples revealed 100%
concordance between the real-time RT-PCR and RT-LAMP assays. These assays had an overall higher
sensitivity than the conventional RT-PCR as they picked up 12 additional samples with a low copy
number of template. Further genotyping through sequence phylogeny revealed that all the WNV isolates
were grouped in lineage I.
Conclusions: The association of West Nile virus with ocular infection in South India during an epidemic of
mysterious fever in the ﬁrst half of 2010 was clearly established through molecular approaches
employing envelope gene-speciﬁc real-time RT-PCR and RT-LAMP assays followed by nucleotide
sequencing.
 2011 International Society for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.
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West Nile virus (WNV) is an arthropod-borne virus that is
taxonomically classiﬁed within the family Flaviviridae, genus
Flavivirus, and is a member of the Japanese encephalitis (JE) virus
serocomplex. WNV circulates in natural transmission cycles
involving primarily Culex species mosquitoes and birds, and
humans are incidental hosts.1 The clinical features of severe
WNV infection vary and include severe headache, ocular mani-
festations, muscle weakness, cognitive impairment, tremors, and a* Corresponding author. Tel.: +91 751 2233495; fax: +91 751 2351148.
E-mail address: paridamm@rediffmail.com (M. Parida).
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doi:10.1016/j.ijid.2011.09.020poliomyelitis-like ﬂaccid paralysis.2,3 Historically, WNV has
circulated primarily in Africa, the Middle East, southern Europe,
Australia, Russia, India, and Indonesia, causing epidemics from
time to time.4–8 However, the recent outbreak of WNV in North
America is of global public health concern.
Routine laboratory diagnosis of WNV infection is primarily
based on serodiagnosis, followed by virus isolation and identiﬁca-
tion. Serologically, WNV infection can be inferred by immuno-
globulin M (IgM) and immunoglobulin G (IgG) capture ELISA.
Recently, several investigators have reported PCR-based detection
systems for the rapid detection of WNV infection in clinical
specimens that are negative for virus isolation, suggesting that
nucleic acid-based assays hold great promise for the detection of
WNV infection.9 In addition, other PCR-based methods, such as theses. Published by Elsevier Ltd. All rights reserved.
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(RT-LAMP) assay, have been developed for the detection of WNV
RNA.10
In late 2009/early 2010, a mysterious viral outbreak in a
southern district of Tamil Nadu affected about 2000 people,
particularly those living in coastal areas, as well as in Chennai,
Tiruvallur, Dharmapuri, Madurai, Theni, and Tirunelveli. The
affected people suffered from high fever and body pain,
particularly acute pain in the joints, which are symptoms of
chikungunya. However, many of them tested negative for
chikungunya virus (CHIKV). Blood samples from the affected
patients were sent for clinical analysis to determine the actual
cause of the illness, but reports were inconclusive due to the
identiﬁcation of different etiologies by different agencies; these
included dengue virus (DENV), CHIKV, and Ross River virus.
The present study describes the clinical observations and
laboratory investigations involving molecular methods performed
on 170 of the 2000 clinically suspected cases. These were cases
who were admitted to Aravind Eye Hospital, Madurai, Tamil Nadu
with ocular complications. Conventional reverse transcription PCR
(RT-PCR) and real-time RT-PCR assays were used to detect WNV
infection. In addition, RT-LAMP was also performed to determine
the feasibility of using this method as an alternative cost-effective
tool to the real-time RT-PCR. Further investigation of the genetic
diversity of the WNV implicated in ocular complications was
undertaken by sequence phylogeny. Data on the clinical picture of
WNV-associated ocular manifestations, along with the sensitivity
and speciﬁcity of the different gene ampliﬁcation assays and
genotyping is discussed.
2. Materials and methods
2.1. Cells and virus strain
The virus strains used in the present study were WNV strain
Eg101, DENV type 2 (DENV-2) strain ThNH7/93, JE virus strain
JaOArS982, St Louis encephalitis (SLE) virus strain Parton, and
yellow fever virus. The viruses were propagated by regular
passaging in Aedes albopictus clone C6/36 cells and titrated by
plaque assay in Vero cells in accordance with the standard
protocol.11,12
2.2. Clinical samples
All patients presenting to the Uveitis Clinic at Aravind Eye
Hospital, Madurai, with signs of acute posterior uveitis and a recent
onset of febrile illness during December 2009 to May 2010 were
enrolled in the study. Demographic details including age, gender,
place of residence, complaints before the onset of eye problems,
and symptoms of ocular illness were recorded. Ophthalmological
examination included visual acuity measurement, slit lamp
biomicroscopy of the anterior and posterior chambers, and indirect
ophthalmoscopic examination.13 Clinical features and factors
potentially contributing to ﬁnal vision loss were also recorded.
In addition, panels of 20 serum samples obtained from apparently
healthy individuals who had not had any fever were included as
negative controls. Informed oral consent was obtained from all
patients. Serum and plasma were collected to perform all the tests.
2.3. Serology
A total of 170 acute phase human patient serum samples were
tested for the presence of CHIKV and DENV using commercial kits.
After ruling out DENV and CHIKV, the remaining samples were
further analyzed by in-house IgM ELISA for WNV.2.4. IgM ELISA
A recombinant envelope (env) protein (r-WNV-env)-based
indirect antibody capture IgM ELISA was optimized for the
detection of WNV-speciﬁc IgM antibodies. Brieﬂy, 96-well
microtiter plates were coated with 300 ng of puriﬁed r-WNV-
env protein in 0.1 M carbonate buffer, pH 9.6. The coated wells
were washed once with 1 phosphate-buffered saline (PBS) and
blocked with 3% bovine serum albumin (BSA) in 1  PBS overnight
at 4 8C. The wells were washed once again with 1  PBS and then
incubated with a 1:100 dilution of patient serum sample in 1  PBS
for 1 h at 37 8C. Wells were washed three times using 1  PBS–
Tween and incubated with anti-human IgM–horseradish peroxi-
dase (HRP) conjugate (1:3000 dilutions in 5% BSA). The wells were
washed once again as above and incubated with 100 ml
tetramethylbenzidine (TMB) substrate for 5 min at room temper-
ature. The reaction was then stopped with 100 ml of 1 N H2SO4 and
the absorbance was recorded at 490 nm in an ELISA reader.
2.5. RT-PCR
All the DENV- and CHIKV-negative samples were tested for the
presence of WNV-speciﬁc RNA by RT-PCR, real-time RT-PCR, and
RT-LAMP assays. RNA was extracted from the patient serum,
plasma, and infected culture supernatant using the QIAamp Viral
RNA Mini Kit in accordance with the manufacturer’s protocol
(Qiagen, Germany). The RNA was then eluted in 50 ml of nuclease-
free water and used as template in the RT-PCR. A one-step RT-PCR
was performed using the Access Quick RT-PCR Kit (Promega,
Madison, WI, USA), in accordance with the manufacturer’s
protocol, employing primer pairs targeting the env gene designed
from the nucleotide sequence of the reference Eg101strain
(GenBank accession number AF260968; a set of forward primer
WNV F: 50 TGG ATT TGG TTC TCG AAG G-30 (genome position
1028–1046) and the reverse primer WNV R: 50 GGT CAG CAC GTT
TGT CAT T-30 (genome position 1228–1210)).
The ampliﬁcation was performed in a 50-ml total reaction
volume with the Promega Access Quick One-Step RT-PCR Kit, with
50 pmol of each forward and reverse primer and 2 ml of extracted
viral RNA, in accordance with the manufacturer’s instructions.
Positive and negative controls were included in each assay run, and
all precautions to prevent cross-contamination were observed.
2.6. Real-time RT-PCR
The WNV env gene-speciﬁc real-time RT-PCR was performed
employing the US Centers for Disease Control and Prevention
(CDC) recommended oligonucleotide primers as well as RT-
LAMP outer primers.10,14 Brieﬂy, the ampliﬁcation was carried
out in 25-ml reaction mixtures using Brilliant SYBR Green
Single-Step QRTPCR Master Mix (Stratagene, USA) containing
12.5 ml of 2 reaction mix, 0.4 ml of reference dye (ROX), 1 ml
(10 pmol) of each forward and reverse primer, 1 ml of RNA,
0.1 ml of reverse transcriptase, and 9.0 ml of nuclease-free water.
‘No-template’, ‘no-primer’, and buffer controls were also
included in the tests.
2.7. RT-LAMP
RT-LAMP was performed at a total reaction volume of 25-ml
using the Loopamp RNA Ampliﬁcation Kit (Eiken Chemical, Tokyo,
Japan) in accordance with the reported protocol.12 Real-time
monitoring was accomplished by incubating at 63 8C for 60 min in
a Loopamp Realtime Turbidimeter (LA-200; Teramecs, Japan).
Real-time monitoring of the RT-LAMP ampliﬁcation of virus
template was observed through spectrophotometric analysis by
Figure 1. Map showing the affected areas of the three different states of South India
during the epidemic (December 2009–May 2010).
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Loopamp Realtime Turbidimeter (LA-200).
2.8. Genotyping
The real-time RT-PCR-positive amplicons were gel puriﬁed and
subjected to double-stranded sequencing with the Big Dye
Terminator Cycle Sequencing Ready Reaction Kit on an ABI 310
sequencer (Applied Biosystems, California, USA). The genotype of
the WNV, based on the partial env gene sequence, was determined
by nucleotide sequencing and compared with 25 other globally
diverse WNV isolates (Table 1). A dendrogram was constructed by
pair-wise comparison of 200 nucleotide sequences of the partial
env gene (positions 1028–1228, with respect to the Eg101
genome), which classiﬁed all isolates into ﬁve different lineages.
The phylogenetic tree was constructed with the neighbor-joining
method, with a bootstrap analysis of 1000 replicates, using MEGA
software, version 2.1.15
3. Results
Of the 170 patients seen at the Aravind Eye Hospital, 105 were
seronegative for DENV and CHIKV. Seventy-eight of these patients
were clinically suspected to have WNV but had negative test
results, and 27 had evidence of WNV by real-time RT-PCR and RT-
LAMP (see below). These 27 patients had developed an acute
posterior uveitis following a febrile illness; 17 were men (63%).
Their age at presentation ranged from 9 to 59 years, with a mean
age of 30 years and median age of 26.5 years. Of these 27 patients,
eight were from the town of Madurai (Tamil Nadu), 15 were from
other parts of Tamil Nadu, and four were from the neighboring
states of Kerala and Andhra Pradesh (Figure 1). The clinical
characteristics of these patients, who showed various presenta-
tions, are outlined in Table 2.
Twenty-ﬁve patients complained of sudden deterioration of
vision in one or both eyes and two had ocular pain in addition to
defective vision. Blurring of vision occurred bilaterally in nine
patients and unilaterally in 18 patients accounting for 36 eyes. Of
36 eyes, 15 had normal vision (Figure 2). Slit lamp examination
showed quiet anterior chamber and no vitreous inﬂammation in
25 patients, and only two patients had 2+ cells and mild ﬂare in theTable 1
Details of West Nile viruses used in this study to compare sequence phylogeny
S. No. Virus strain Year of sample c
1 Mex03 2004 
2 NY99 2005 
3 TVP-9376 2005 
4 IS-98STD 2002 
5 TX2002 2 2005 
6 Goose-Hungry/03 2005 
7 Ast02-2-692 2006 
8 PaH001 2003 
9 WN Italy 1998-equine 2001 
10 96-111 2004 
11 KN3829 2003 
12 RO97-50 2000 
13 LEIV-Vlg00-27924 2003 
14 Eg101 2000 
15 Kunjin virus 1988 
16 Rabensburg isolate 97-103 2004 
17 H442 2007 
18 SA381/00 2007 
19 Goshawk-Hungary/04 2005 
20 B956 2004 
21 SPU116/89 2007 
22 SA93/01 2007 
23 804994 2005 
24 LEIV-Krnd88-190 2003 anterior segment. Fundus examination showed the presence of
neuroretinitis in 11 patients, retinitis alone in six, and vasculitis in
nine patients, as predominant posterior segment signs. During the
active phase, other features seen in the posterior segment
examination included discrete deep, white retinitis, retinal edema
along the retinal vessels near the disc, and macular star.
A comparative analysis of blood specimens obtained from the
170 patients with suspected WNV infection was conducted using
serology, RT-PCR, real-time RT-PCR, and RT-LAMP. Out of the 170
samples, 25 were positive for chikungunya IgM antibody (15%), 10
for chikungunya antigen (6%), and 30 were positive for dengue IgM
(18%). The remaining 105 seronegative samples were furtherollection Country GenBank accession No.
Mexico AY660002
USA DQ211652
USA AY848697
France AF481864
USA DQ164205
Hungary DQ118127
Russia DQ411035
France AY268133
USA AF404757
France AY701412
France AY262283
USA AF260969
Russia AY278442
USA AY260968
Australia D00246
Austria AY765264
South Africa EF429200
South Africa EF429199
Hungary DQ116961
USA AY532665
South Africa EF429197
South Africa EF429198
India DQ256376
Russia AY277251
Table 2
Clinical characteristics of patients with febrile illness, December 2009 to May 2010,
in South India
Characteristic Number %
Chronicity
Acute 27 100%
Chronic Nil
Laterality
Unilateral 18 66.7%
Bilateral 9 33.3%
Pattern of anterior inﬂammation
Granulomatous Nil
Non-granulomatous 2 7.4%
Location
Posterior 25 92.6%
Diffuse 2 7.4%
Neuroretinitis 11 40.7%
Retinal vasculitis 9 33.3%
Retinitis 6 22.2%
Vascular occlusion 2 7.4%
Bilateral combined vascular occlusion 2 7.4%
Foveolitis 1 3.7%
Recurrences Nil Nil
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methods. Out of the 105 samples, 35 (33%) were positive for WNV
IgM antibody, 15 (14%) were positive for WNV by RT-PCR, and 27
(26%) were found to be positive for WNV by real-time RT-PCR and
by RT-LAMP assays (Table 3). All real-time RT-PCR and RT-LAMP
positive samples also showed positivity by CDC reported real-time
RT-PCR assay. Comparative evaluation with acute-phase patient
serum samples revealed 100% concordance between the real-time
PCR and RT-LAMP assays. These assays had an overall higher
sensitivity than the conventional RT-PCR as they picked up 12
additional samples with a low copy number of template. There was
no cross-reactivity of real-time RT-PCR and RT-LAMP assays with
other closely related ﬂaviviruses or with healthy individual panel
samples.
Real-time RT-PCR amplicons of the 27 WNV-positive samples
were puriﬁed and sequenced by Sanger’s dideoxy chain termina-
tion method (Figure 3). The nucleotide sequence of the partial env
gene junction (201 bp) of the WNV conserved region wasFigure 2. Scatter plot showing initial and ﬁnal visual acuity. The diagonal line shows
eyes with no change in vision. Points above the line show eyes that worsened and
points below the line show eyes that improved.deciphered. The nucleotide sequences were subjected to BLAST
search to ﬁnd the closest sequence identity. The WNV sequences
revealed closest sequence identity with isolates of genogroup I
lineage circulating in North Africa and South America. These
sequences were compared with WNV prototype strain (Eg101). All
these sequences were aligned with the homologous regions
(nucleotides 1–201) of prototype Eg101 strain and submitted to
GenBank. The GenBank accession numbers are given in Table 4. The
alignment did not reveal any base insertion or deletion in this
region. On comparison to the prototype strain, the majority of
mutations were found to be silent. The deduced amino acids were
also aligned following the nucleotide alignment pattern. The
majority of amino acid changes were found to be of conservative
type. On comparison of the gene region, it was found that all WNV
isolates were very closely related (90.0% at the nucleotide level and
91.7% at the deduced amino acid level) to the prototype strain. The
phylogenetic analysis was carried out based on the nucleotide
sequence of the partial gene sequence region (nucleotide positions
1028–1228). A dendrogram based on the env gene junction region
clearly revealed that all the WNV isolates were grouped in lineage I
(Figure 4).
4. Discussion
WNV is an emerging virus infection across the globe. Several
outbreaks of varying degrees of severity have been reported from
different countries.16–18However human ocular infection with WNV
has not been reported in India so far. Based on clinical presentation, it
is difﬁcult to distinguish between the different Flavivirus group
infections, as their systemic clinical signs overlap and the clinical
picture is non-speciﬁc. Laboratory support is crucial for a deﬁnitive
diagnosis of dengue, chikungunya, or WNV.19
In the present study, of 27 WNV patients, six did not have any
systemic illness and two had a severe systemic illness with viral
meningitis. During the previous outbreak of chikungunya viral
infection in South India in 2005/2006, constitutional symptoms and
arthralgia were very common clinical signs. Several patients in the
2009/2010 outbreak presenting with these symptoms developed
post-febrile visual morbidity and were thus screened for chikungu-
nya and dengue antibody by serology. These patients tested negative
for all these serological tests. In addition to reported systemic
symptoms such as headache, myalgia, arthralgia, malaise, nausea,
vomiting, and pharyngitis, 11 patients had facial pigmentation and
generalized hyper-pigmentation, and six patients also reported
generalized anasarca during the febrile stage.
Although non-granulomatous uveitis and vitritis have been
reported previously in WNV ocular infection,20,21 in 25 out of 27
patients in our series, inﬂammatory cells were absent in the
anterior segment and vitreous, despite the presence of retinitis.
However, clear vitreous has also been observed by previous
investigators in patients with WNV ocular disease.22 AmongFigure 3. West Nile virus envelope gene-speciﬁc RT-PCR amplicons (201 bp) as
observed on 2% agarose gel analysis under UV illumination.
Table 3
Comparative analysis of the results of tests for the detection of West Nile virus in suspected cases of West Nile infection
Results RT-PCR (n = 105)a Real-time RT-PCR (n = 105)a RT-LAMP (n = 105)a IgM detection (n = 105)a
Positive 15 (14%) 27 (26%) 27 (26%) 35 (33%)
Negative 90 (86%) 78 (74%) 78 (74%) 70 (67%)
RT-PCR, reverse transcription polymerase chain reaction; RT-LAMP, reverse transcription loop-mediated isothermal gene ampliﬁcation.
a n = the number of suspected cases screened for West Nile infection.
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vascular involvement have been recognized as common, self-
limiting ocular manifestations.23,24 Kaiser et al. described a
diabetic patient who had moderate visual impairment and
multiple branch artery occlusions.25 Khairallah et al. related the
linear distribution of chorioretinitis with retinal nerve ﬁber
organization,26 suggesting a contiguous spread of WNV from the
central nervous system via the optic nerve ﬁbers to the outer
retina, retinal pigment epithelium, and choroids.27 Multiple small,
round, scattered chorioretinal lesions in the posterior and
peripheral fundus and optic neuritis have also been reported
previously.28,29 Linear chorioretinitis was not seen in our patients;
instead, a uniformly similar fundus picture of clear vitreous,
retinitis near the disc, vasculitis, and macular star with hyperemic
disc were predominantly noted in the majority of patients.
Common causes of retinitis and vasculitis in our population
include toxoplasmosis, syphilis, herpetic viral retinitis, and
occasionally tuberculosis. All these causes are known for theirFigure 4. Phylogenetic analysis based on the 201-bp (positions 1028–1228) partial envel
Nadu, India with respect to other global isolates. The encircled clusters are the sampleintense vitreous reaction, which was not present in these patients.
Systemic evaluation also ruled out the possibility of tuberculosis or
syphilis. Toxoplasmosis and syphilis serology were negative.
Interestingly two patients who had high-grade fever presented
to us with combined retinal arterial and venous occlusion, and they
had very poor visual recovery.
This study identiﬁed the presence of WNV infection in southern
India by real-time RT-PCR and RT- LAMP assays and found
neuroretinitis and retinitis to be the most common ocular ﬁndings.
We also found that the majority of patients had a good prognosis.
Real-time RT-PCR and RT-LAMP assays can be used as diagnostic
tools, and the RT-LAMP assay is more cost-effective with the same
effectiveness as RT-PCR and real-time RT-PCR. Real-time RT-PCR
assays using either probes with Taqman technology or SYBR Green
have been developed for the detection of WNV infection.30–32
Recently, other PCR-based methods such as the RT-LAMP assay
have been developed by targeting the env gene of WNV. The RT-
LAMP assay is a novel method of gene ampliﬁcation that ampliﬁesope gene of West Nile virus associated with ocular manifestations in Madurai, Tamil
s sequenced in this study; their GenBank accession numbers are given in Table 4.
Table 4
Details of West Nile viruses sequenced in this study
S. No. Virus strain Year of sample
collection
Country GenBank
accession No.
1 DRDE WNV-01 2010 India JN591727
2 DRDE WNV-02 2009 India JN591728
3 DRDE WNV-03 2009 India JN591729
4 DRDE WNV-04 2009 India JN591730
5 DRDE WNV-05 2010 India JN591731
6 DRDE WNV-06 2010 India JN591732
7 DRDE WNV-07 2010 India JN591733
8 DRDE WNV-08 2010 India JN591734
9 DRDE WNV-09 2010 India JN591735
10 DRDE WNV-10 2010 India JN591736
11 DRDE WNV-11 2010 India JN591737
12 DRDE WNV-12 2010 India JN591738
13 DRDE WNV-13 2009 India JN591739
14 DRDE WNV-14 2009 India JN591740
15 DRDE WNV-15 2010 India JN591741
16 DRDE WNV-16 2010 India JN591742
17 DRDE WNV-17 2010 India JN591743
18 DRDE WNV-18 2010 India JN591744
19 DRDE WNV-19 2010 India JN591745
20 DRDE WNV-20 2010 India JN591746
21 DRDE WNV-21 2010 India JN591747
22 DRDE WNV-22 2009 India JN591748
23 DRDE WNV-23 2009 India JN591749
24 DRDE WNV-24 2009 India JN591750
25 DRDE WNV-25 2009 India JN591751
26 DRDE WNV-26 2010 India JN591752
27 DRDE WNV-27 2010 India JN591753
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isothermal conditions, with a set of six specially designed primers
that recognize eight distinct sequences of the target.
In the present study, the detection of WNV RNA in 14% of
samples by RT-PCR and the 26% positivity by real-time RT-PCR and
RT-LAMP, conﬁrmed that the causative agent of this epidemic was
WNV. All 78 patients who had clinically suspected WNV but whose
real-time RT-PCR and RT-LAMP results were negative presented
more than 7 days after the onset of fever; this may be the reason for
the negative test results due to low transient viremia. The
maximum number of PCR-positive results was observed on day
2 of illness.
In order to furnish the direct sequence information from the
patient about the virus genotype, a short 201-bp fragment of the
env gene from the real-time RT-PCR was selected for sequencing
without passaging in a heterologous system. The env gene is the
ideal target for genetic diversity studies owing to its immuno-
dominant nature, which makes it subject to positive selection
pressure. Previous phylogenetic analysis based on the 201-bp
partial env gene sequence initially grouped WNV into two main
phylogenetic lineages.33 Strains from lineage I were restricted to
North Africa, Asia, Europe, and North and South America, as well
as Australia. Lineage II strains were in turn thought to circulate
exclusively in southern Africa and Madagascar. These investiga-
tions subsequently subdivided lineage I strains into three sub-
clades, with clade 1A representing strains from Africa, Asia, the
Middle East, and America, clade 1B representing Australian
strains (Kunjin), and clade 1C including isolates from India. It
was then proposed that clade 1C represented a separate lineage
(lineage V). Two new lineages have recently been described,
namely Rabensburg virus (lineage III), isolated from a Culex
mosquito at the border between Austria and the Czech Republic,
and a proposed lineage IV strain identiﬁed in ticks in the
Caucasus. Although it may be plausible that these new viruses
represent individual ﬂaviviruses that belong to the Japanese
encephalitis serocomplex, phylogenetic analysis groups them
with WNV.34In conclusion, this is the ﬁrst report on the implications of West
Nile virus with ocular infection in India. The molecular techniques
of real-time RT-PCR and RT-LAMP are useful for early, reliable, and
rapid conﬁrmation when there is a clinical suspicion.
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